Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders

被引:200
作者
Kawazu, M
Kanda, Y
Nannya, Y
Aoki, K
Kurokawa, M
Chiba, S
Motokura, T
Hirai, H
Ogawa, S
机构
[1] Univ Tokyo, Grad Sch Med, Dept Regenerat Med Hematopoiesis, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Cell Therapy & Transplantat Med, Tokyo 1138655, Japan
关键词
D O I
10.1128/JCM.42.6.2733-2741.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The establishment of an optimal noninvasive method for diagnosing invasive aspergillosis (IA) is needed to improve the management of this life-threatening infection in patients with hematological disorders, and a number of noninvasive tests for IA that target different fungal components, including galactomannan, (1-->3)-beta-D-glucan (BDG), and Aspergillus DNA, have been developed. In this study, we prospectively evaluated the diagnostic potential of three noninvasive tests for IA that were used in a weekly screening strategy: the double-sandwich enzyme-linked immunosorbent assay (ELISA) for galactomannan (Platelia Aspergillus), a real-time PCR assay for Aspergillus DNA (GeniQ-Asper), and an assay for BDG (beta-glucan Wako). We analyzed 149 consecutive treatment episodes in 96 patients with hematological disorders who were at high risk for IA and diagnosed 9 proven IA cases, 2 probable IA cases, and 13 possible invasive fugal infections. In a receiver-operating characteristic (ROC) analysis, the area under the ROC curve was greatest for ELISA, using two consecutive positive results (0.97; P = 0.036 for ELISA versus PCR, P = 0.055 for ELISA versus BDG). Based on the ROC curve, the cutoff for the ELISA could be reduced to an optical density index (O.D.I.) of 0.6. With the use of this cutoff for ELISA and cutoffs for PCR and BDG that give a comparable level of specificity, the sensitivity/specificity/positive predictive value/negative predictive value of the ELISA and the PCR and BDG tests were 1.00/0.93/0.55/1.00, 0.55/0.93/0.40/0.96, and 0.55/0.93/0.40/0.96, respectively. In conclusion, among these weekly screening tests for IA, the double-sandwich ELISA test was the most sensitive at predicting the diagnosis of IA in high-risk patients with hematological disorders, using a reduced cutoff of 0.6 O.D.I.
引用
收藏
页码:2733 / 2741
页数:9
相关论文
共 35 条
[1]   Diagnosis of pulmonary aspergillosis using optical brighteners [J].
Andreas, S ;
Heindl, S ;
Wattky, C ;
Möller, K ;
Rüchel, R .
EUROPEAN RESPIRATORY JOURNAL, 2000, 15 (02) :407-411
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   Quantitative galactomannan detection is superior to PCR in diagnosing and monitoring invasive pulmonary aspergillosis in an experimental rat model [J].
Becker, MJ ;
de Marie, S ;
Willemse, D ;
Verbrugh, HA ;
Bakker-Woudenberg, IAJM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (04) :1434-1438
[4]   A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients [J].
Bowden, R ;
Chandrasekar, P ;
White, MH ;
Li, X ;
Pietrelli, L ;
Gurwith, M ;
van Burik, JA ;
Laverdiere, M ;
Safrin, S ;
Wingard, JR .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :359-366
[5]   Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis [J].
Bretagne, S ;
Costa, JM ;
Bart-Delabesse, E ;
Dhédin, N ;
Rieux, C ;
Cordonnier, C .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (06) :1407-1412
[6]   Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction:: Clinical results [J].
Buchheidt, D ;
Baust, C ;
Skladny, H ;
Ritter, J ;
Suedhoff, T ;
Baldus, M ;
Seifarth, W ;
Leib-Moesch, C ;
Hehlmann, R .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :428-435
[7]   Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia [J].
Caillot, D ;
Couaillier, JF ;
Bernard, A ;
Casasnovas, O ;
Denning, DW ;
Mannone, L ;
Lopez, J ;
Couillault, G ;
Piard, F ;
Vagner, O ;
Guy, H .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :253-259
[8]   Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery [J].
Caillot, D ;
Casasnovas, O ;
Bernard, A ;
Couaillier, JF ;
Durand, C ;
Cuisenier, B ;
Solary, E ;
Piard, F ;
Petrella, T ;
Bonnin, A ;
Couillault, G ;
Dumas, M ;
Guy, H .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :139-147
[9]   Real-time PCR coupled with automated DNA extraction and detection of galactomannan antigen in serum by enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis [J].
Costa, C ;
Costa, JM ;
Desterke, C ;
Botterel, F ;
Cordonnier, C ;
Bretagne, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :2224-2227
[10]   Therapeutic outcome in invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :608-615